Treatment with anti-amyloid β antibodies is becoming standard therapy for early Alzheimer's disease, as lecanemab and donanemab received full approval in the USA, Japan, and other countries between ...

There's still more than two months until the 2026 Maryland General Assembly kicks off, but on Tuesday, local officials struck ...

New AI agent delivers quotes up to three times faster, doubles call-to-bind conversion, and gives producers more time to ...

Here's everything Houston Texans head coach DeMeco Ryans said following their bye week, including an update on the offensive ...

In the past, the word braindump referred to people who memorized real exam questions and shared them online. That violates ...

Financial innovation in digital assets is rapidly transforming the American economy, promising a new era of financial opportunity and global competitiveness. To seize this moment, Washington must ...

There's no assurance the University of Arizona would actually get funding benefits for complying, the Regents professors warn ...

Oral presentation to highlight initial data from ongoing pivotal Phase 2 study of rezatapopt, a first-in-class precision oncology investigational therapy, in patients with advanced solid tumors ...

Humans have about 400 odorant receptors (ORs), but scientists have had trouble finding ligands that match up with most of ...

On October 6, the City of Burlington held their monthly Committee of the Whole meeting to discuss various items relevant to ...

Another data center broke ground in Cheyenne on Tuesday, starting a $1.2 billion development on 115 acres at Campstool ...

AdvantageGo, a Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a global leader in intelligent SaaS-based ...